Search research articles
Contact Us
Filters
Showing results (1-10 of 40) with videos related to
Page
of 4
Sort By:
Clinical Pharmacokinetics
|
May 3, 2019
Comment on "Target-Controlled Continuous Infusion for Antibiotic Dosing: Proof-of-Principle in an In-silico Vancomycin Trial in Intensive Care Unit Patients"
Iris K Minichmayr, Markus Zeitlinger
The New England Journal of Medicine
|
September 3, 2025
Malnutrition in Older Adults
Iris K Minichmayr, Markus Zeitlinger
Clinical Pharmacology and Therapeutics
|
March 18, 2026
Pharmacogenetics-Not Just Low-Hanging Fruit
Ingolf Cascorbi, Iris K Minichmayr
International Journal of Antimicrobial Agents
|
June 8, 2024
Impact of continuous-infusion meropenem degradation and infusion bag changes on bacterial killing of Pseudomonas aeruginosa based on model-informed translation
Iris K Minichmayr, Lena E Friberg
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
November 20, 2013
Population pharmacokinetics meets microdialysis: benefits, pitfalls and necessities of new analysis approaches for human microdialysis data
André Schaeftlein, Iris K Minichmayr, Charlotte Kloft
Pharmaceutical Research
|
March 18, 2021
Pharmacometrics-Based Considerations for the Design of a Pharmacogenomic Clinical Trial Assessing Irinotecan Safety
Iris K Minichmayr, Mats O Karlsson, Siv Jönsson
International Journal of Antimicrobial Agents
|
June 12, 2022
Pharmacokinetic/pharmacodynamic models for time courses of antibiotic effects
Iris K Minichmayr, Vincent Aranzana-Climent, Lena E Friberg
Pharmaceutical Research
|
December 20, 2024
A Model-Based Evaluation of Noninvasive Biomarkers to Reflect Histological Nonalcoholic Fatty Liver Disease Scores
Iris K Minichmayr, Elodie L Plan, Benjamin Weber, et al.
Clinical Pharmacokinetics
|
October 19, 2016
Clinical Determinants of Target Non-Attainment of Linezolid in Plasma and Interstitial Space Fluid: A Pooled Population Pharmacokinetic Analysis with Focus on Critically Ill Patients
Iris K Minichmayr, André Schaeftlein, Joseph L Kuti, et al.
Antibiotics (Basel, Switzerland)
|
August 26, 2022
Model-Informed Translation of In Vitro Effects of Short-, Prolonged- and Continuous-Infusion Meropenem against <i>Pseudomonas aeruginosa</i> to Clinical Settings
Iris K Minichmayr, Suzanne Kappetein, Margreke J E Brill, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 40) with videos related to
Sort By:
Page
of 4
Clinical Pharmacokinetics
|
May 3, 2019
Comment on "Target-Controlled Continuous Infusion for Antibiotic Dosing: Proof-of-Principle in an In-silico Vancomycin Trial in Intensive Care Unit Patients"
Iris K Minichmayr, Markus Zeitlinger
The New England Journal of Medicine
|
September 3, 2025
Malnutrition in Older Adults
Iris K Minichmayr, Markus Zeitlinger
Clinical Pharmacology and Therapeutics
|
March 18, 2026
Pharmacogenetics-Not Just Low-Hanging Fruit
Ingolf Cascorbi, Iris K Minichmayr
International Journal of Antimicrobial Agents
|
June 8, 2024
Impact of continuous-infusion meropenem degradation and infusion bag changes on bacterial killing of Pseudomonas aeruginosa based on model-informed translation
Iris K Minichmayr, Lena E Friberg
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
November 20, 2013
Population pharmacokinetics meets microdialysis: benefits, pitfalls and necessities of new analysis approaches for human microdialysis data
André Schaeftlein, Iris K Minichmayr, Charlotte Kloft
Pharmaceutical Research
|
March 18, 2021
Pharmacometrics-Based Considerations for the Design of a Pharmacogenomic Clinical Trial Assessing Irinotecan Safety
Iris K Minichmayr, Mats O Karlsson, Siv Jönsson
International Journal of Antimicrobial Agents
|
June 12, 2022
Pharmacokinetic/pharmacodynamic models for time courses of antibiotic effects
Iris K Minichmayr, Vincent Aranzana-Climent, Lena E Friberg
Pharmaceutical Research
|
December 20, 2024
A Model-Based Evaluation of Noninvasive Biomarkers to Reflect Histological Nonalcoholic Fatty Liver Disease Scores
Iris K Minichmayr, Elodie L Plan, Benjamin Weber, et al.
Clinical Pharmacokinetics
|
October 19, 2016
Clinical Determinants of Target Non-Attainment of Linezolid in Plasma and Interstitial Space Fluid: A Pooled Population Pharmacokinetic Analysis with Focus on Critically Ill Patients
Iris K Minichmayr, André Schaeftlein, Joseph L Kuti, et al.
Antibiotics (Basel, Switzerland)
|
August 26, 2022
Model-Informed Translation of In Vitro Effects of Short-, Prolonged- and Continuous-Infusion Meropenem against <i>Pseudomonas aeruginosa</i> to Clinical Settings
Iris K Minichmayr, Suzanne Kappetein, Margreke J E Brill, et al.
Page
of 4